Darunavir
Brand name: Prezista
Rank #266 of 500 drugs by total cost
$46.0M
Total Cost
21,793
Total Claims
$46.0M
Total Cost
907
Prescribers
$2,113
Cost per Claim
472
Beneficiaries
22,559
30-Day Fills
$51K
Avg Cost/Provider
24
Avg Claims/Provider
About Darunavir
Darunavir (sold as Prezista) was prescribed 21,793 times by 907 Medicare Part D providers in 2023, costing the program $46.0M. At $2,113 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 263 | Pembrolizumab (Keytruda) | $46.9M | 3,947 |
| 264 | Glipizide (Glipizide) | $46.9M | 2,961,035 |
| 265 | Losartan/Hydrochlorothiazide (Losartan-Hydrochlorothiazide) | $46.3M | 2,039,676 |
| 266 | Darunavir (Prezista) | $46.0M | 21,793 |
| 267 | C1 Esterase Inhibitor (Haegarda) | $45.8M | 894 |
| 268 | Alectinib Hcl (Alecensa) | $45.7M | 2,686 |
| 269 | Ipratropium Bromide (Ipratropium Bromide) | $45.4M | 656,249 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology